Nebracetam
Nebracetam is an investigational drug of the racetam family that is a M1 acetylcholine receptor agonist in rats.[1] Its effects in humans have not been studied.
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C12H16N2O |
Molar mass | 204.268 g/mol g·mol−1 |
3D model (JSmol) | |
Chirality | Racemic mixture |
SMILES
| |
InChI
| |
|
See also
References
- Takeo, S.; Hayashi, H.; Miyake, K.; Takagi, K.; Tadokoro, M.; Takagi, N.; Oshikawa, S. (1997). "Effects of delayed treatment with nebracetam on neurotransmitters in brain regions after microsphere embolism in rats". British Journal of Pharmacology. 121 (3): 477–484. doi:10.1038/sj.bjp.0701161. PMC 1564714. PMID 9179389.
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.